AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Bittium Oyj

Director's Dealing May 9, 2017

3258_dirs_2017-05-09_fe7cd5fb-075a-44c6-9489-50fff9c742e7.pdf

Director's Dealing

Open in Viewer

Opens in native device viewer

Bittium Corporation: Notification of managers' transactions

Stock exchange release

Free for publication on May 9, 2017 at 10.01 am (CEST+1)

Bittium Corporation: Notification of managers' transactions

Person subject to the notification requirement

Name: Juha Putkiranta Position: Member of the Board of Directors

Notification type: Initial Notification Reference number: 743700NFG5W5I59OVX65_20170508094211_2

Issuer: Bittium Corporation LEI: 743700NFG5W5159OVX65

Transaction date: May 5, 2017 Venue: XHEL Instrument: Share ISIN: FI0009007264 Nature of transaction: Receipt of a Share-Based Incentive

Transaction details

  • (1) Volume: 900 Unit price: EUR 6.39000
  • (2) Volume: 200 Unit price: EUR 6.39000
  • (3) Volume: 200 Unit price: EUR 6.39000
  • (4) Volume: 200 Unit price: EUR 6.39000

Aggregated transactions

Volume: 1 500 Volume weighted average price: EUR 6.39000

Oulu, May 9, 2017 Hannu Huttunen CEO

Further information:

Kari Jokela CLO Tel. +358 40 344 5466

Distribution:

Nasdaq Helsinki Ltd Main media

Bittium

Bittium specializes in the development of reliable, secure communications and connectivity solutions leveraging its 30 year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. Complementing its communications and connectivity solutions, Bittium offers proven information security solutions for mobile devices and portable computers. From November 2016 onwards, Bittium offers its customers also healthcare technology products and services in biosignal measuring in the areas of cardiology, neurology, rehabilitation, occupational health and sports medicine. Net sales in 2016 was EUR 64.2 million and operating profit was EUR 2.5 million. Bittium is listed on Nasdaq Helsinki. www.bittium.com.

Talk to a Data Expert

Have a question? We'll get back to you promptly.